SG Americas Securities’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

SG Americas Securities’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,971	Closed	-$1.38M	–	3042
2015 Q1	$1.38M	Sell	7,971 -4,931	-38%	-$724K	0.01%	968
2014 Q4	$1.48M	Buy	12,902 +2,076	+19%	+$251K	0.01%	1077
2014 Q3	$1.69M	Sell	10,826 -14,196	-57%	-$2.06M	0.01%	944
2014 Q2	$3.09M	Sell	25,022 -8,496	-25%	-$939K	0.02%	787
2014 Q1	$3.47M	Buy	33,518 +24,290	+263%	+$2.49M	0.02%	739
2013 Q4	$830K	Sell	9,228 -35,137	-79%	-$2.8M	﹤0.01%	1290
2013 Q3	$2.97M	Buy	+44,365	New	+$3.06M	0.01%	789

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

SG Americas Securities's SLXP Position: Q2 2015 in Review

SG Americas Securities sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 7,971 shares — an estimated $1.38M sold.

SG Americas Securities first reported a position in SLXP in Q3 2013 and held it in 7 quarters. The position peaked at $3.47M in Q1 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

SG Americas Securities reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
SG Americas Securities sold 7,971 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.38M.
SG Americas Securities first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 7 quarters.
SG Americas Securities's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.47M in Q1 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on SG Americas Securities's 13F filing for Q2 2015, filed 6 Aug 2015.